pharmaceuticals

Aurobindo Pharma Q4 FY 2022 Research Tear Sheet

● Jun 6, 2022

Aurobindo Pharma Limited is an Indian pharmaceutical company. It was established in the year 1986. The founders include Mr. P.V....

Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights

● Jun 6, 2022

Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3 ANDAs...

Hikal Limited Q4 FY22 Earnings Conference Call Insights

● Jun 6, 2022

Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in anti-diabetic...

Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights

● Jun 2, 2022

Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues to...

Aurobindo Pharma Ltd (AUROPHARMA) Q4 FY22 Earnings Concall Transcript

● Jun 1, 2022

Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur — Investor Relations Santhanam Subramanian — Chief...

Piramal Enterprises Ltd Q4 FY22 Earnings Conference Call Insights

● Jun 1, 2022

Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire...

Torrent Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights

● May 26, 2022

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about...

Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights

● May 24, 2022

Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the company’s...

Divi’s Laboratories Ltd Q4 FY22 Earnings Conference Call Insights

● May 24, 2022

Key highlights from Divi’s Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue for...

Dr. Reddy’s Laboratories (DRREDDY) Q4 FY22 Earnings Concall Transcript

● May 20, 2022

Dr. Reddy’s Laboratories (NSE: DRREDDY) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Amit Agarwal — Head of Investor Relations...